StockData

Aimei Health Technology Co., Ltd. (AFJK) stock

AFJKNasdaqBlank ChecksFiscal year ends December 31Also trades as AFJKR, AFJKU
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$11.81−0.03 (-0.25%)

Close on Nov 18, 2026Market cap $37.39MP/E –Yield –

Aimei Health Technology operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Aimei Health Technology's operating income for the twelve months ending Sep 30, 2026 was -$649.67K. For fiscal 2025 it was -$835.76K.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$835.76K–
FY2024Dec 31, 2024-$1.06M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$144.75K–
Q2 FY2026Jun 30, 2026-$192.35K–
Q1 FY2026Mar 31, 2026-$61.98K–
Q4 FY2025Dec 31, 2025-$250.59K–
Q3 FY2025Sep 30, 2025-$130.15K–
Q2 FY2025Jun 30, 2025-$41.60K–
Q1 FY2025Mar 31, 2025-$413.41K–
Q4 FY2024Dec 31, 2024-$402.02K–
Q3 FY2024Sep 30, 2024-$200.02K–
Q2 FY2024Jun 30, 2024-$309.11K–
Q1 FY2024Mar 31, 2024-$153.63K–

More Aimei Health Technology figures

See a number that looks wrong?